Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer
Maya Jeitany(Commissariat à l'Énergie Atomique et aux Énergies Alternatives), Audrey Sirvent(Centre National de la Recherche Scientifique)
Cited by 111
Related Papers
TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines
|Gastroenterology|2020|186
SLAP controls mTORC2 integrity via UBE3C-mediated non-degradative mLST8 ubiquitination to suppress colorectal tumorigenesis
|Cell Death and Differentiation|2025|3